Submission process

Manuscript must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The submitting author takes responsibility for the article during submission and peer review. To facilitate rapid publication and to minimize administrative cost, NDJMMR accepts only online submissions. All manuscript are to be submitted online as an attached email to: ndjmmrbayelsa@gmail.com

At submission you are required to provide cover letter. Use this to explain why your manuscript should be published in the journal, to elaborate on any issues relating to our editorial policies, and to declare any potential conflicting interests. You should also provide the contact details (including name, affiliation and email addresses) of four potential peer reviewers for your manuscript. These should be experts in the field, who will be able to provide an objective assessment of the manuscript. Any suggested peer reviewers should not have published with any of the authors of the manuscript within the past five years, should not be current collaborators, and should not be members of the same research institution. Suggested reviewers will be considered alongside potential reviewers recommended by the Editorial Board members or advisers.

File formats

The following word processor file formats are acceptable for the main manuscript document:

• Microsoft word (DOC, DOCX)
• Portable document format (PDF)

Note that figures may be submitted as part of the submitted manuscript file or as separate image files.

Preparing main manuscript text

General guidelines of the journal’s style and language are given below.

Overview of manuscript sections for Research Articles

Manuscript for research articles submitted to NDJMMR should be divided into the following sections (in this order):

• Title page
• Abstract
• Keywords
• Background
• Methods
• Results
• Discussion
• Conclusions
• List of abbreviations used (if any)
• Competing interest
• Authors contributions
• Authors information
• Acknowledgements
• Endnotes
• References
• Illustrations and figures (if any)
• Tables and captions

Title page

The title page should:

• provide the title of the article
• List full names, institutional addresses and email addresses for all authors.
• Indicate the corresponding author

Abstract

The abstract of the manuscript should not exceed 250 words and must be structured into separate sections: Background, the context and purpose of the study; Methods, how the study was performed and statistical test used; Results, the main findings; Conclusions, brief summary and potential implications. Please, minimize the use of abbreviations and do not cite references in the abstract.

Key words

Three to ten keywords representing the main content of the article.

Background

The background section should be written in a way that is accessible to researchers without specialist knowledge in that area and must clearly state and illustrate the background to the research and its aims. Reports of clinical research should, where appropriate, include a summary of a search of the literature to indicate why this study was necessary and what it aimed to contribute to the field. The section should end with a brief statement of what is being reported in the article.

Methods

The methods section should include the design of the study, the setting, the type of participants or materials involved, a clear description of all interventions and comparisons, and the type of analysis used, including a power calculator if appropriate. Generic drug names should generally be used. When proprietary brands are used in research, include the brand names in parentheses in the Method section. For studies involving human participations a statement detailing ethical approval and consent should be included in method section.

Results and discussion

The Results and discussion may be combined into a single section or presented separately. Results of statistical analysis should be included, where appropriate, relative and absolute risks or risk reduction, and confidence intervals. The results and discussion sections may also be broken into subsection with short, informative headings

Conclusion

This should state clearly the main conclusion of research and give a clear explanation of their importance and relevance. Summary illustration may be included.

List of abbreviations

If abbreviations are used in the text they should be defined in the text at first use, and a list of abbreviation can be provided, which should precede the competing interests and authors’ contributions.

Competing interests

A competing interest exists when your interpretation of data presentation of information may be influenced by your personal or financial relationship with other people or organizations. Authors must disclose any financial competing interest; they should also reveal any nonfinancial competing interests that may cause them embarrassment were they to become public after the publication of the manuscript.

Authors are required to complete a declaration of competing interests. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read ‘The author(s) declare that they have no competing interest’.

When completing your declaration, please consider the followings:

Financial competing interests

• In the past five years have you received reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such organization financing this manuscript (including the article-processing charge)? If so, please specify.
• Do you hold any stocks or shares in an organization that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so please specify.
• Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organization that holds or has applied for patents relating to the content of the manuscript? If so, specify.
• Do you have any other financial competing interest? If so, please specify.

Non-financial competing interests

Are there any non-financial competing interests (political, personal, religious, ideological, academic, intellectual, commercial or any other) to declare in relation to this manuscript? If so, please specify.

If you are unsure as to whether you, or one your co-authors, has a competing interest please discuss it with the editorial office.

Authors’ contributions

In order to give appropriate credit to each author or a paper, the individual contributions of authors to the manuscript should be specified in this section.

An ‘author’ is generally considered to be someone who has made substantive intellectual contributions to a published study. To qualify as an author one should 1) have made substantive contributions to conception and design, or acquisition of data, or analysis and interpretation of data; 2) have been involved in drafting the manuscript or revising for critically for important intellectual content; and 3) have given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portion of the content. Acquisition of funding, collection of data, or general supervision of research group, alone, does not justify authorship.

We suggest the following kind of format (please use initials to refer to each author’s contribution): AB carried out the molecular genetic studies, participated in the sequence alignment and drafted the manuscript. JY carried out the immunoassays. MT participated in the sequence alignment.ES participated in the design of the study and performed the statistical analysis. FG conceived of the study, and participated in the design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

All contributors who do not meet the criteria for authorship should be listed in the acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chair that provided only general support.

Authors’ information

You may choose to use this section to include any relevant information about the author(s) that may aid the reader’s interpretation of the article, and understand the standpoint of the author(s).

This may include details about the author’s qualifications, current positions they hold at institutions or societies, or any other relevant background information. Please refer to authors using their initials. Note this section should not be used to describe competing interests.

Acknowledgement

Please acknowledge anyone who contributed towards the article by making substantial contributions to conception, design, acquisition of data, or analysis and interpretation of data, or who was involved in drafting the manuscript or revising it critically for important intellectual content, but who does not meet the criteria for authorship. Please also include the source(s) of funding for each author, and for the manuscript preparation. Authors must describe the role of the funding bodies, if any, in design, in the collection, analysis, the interpretation of data, in the writing of the manuscript; and in the decision to submit the manuscript for publication. Please also acknowledge anyone who contributed materials essential for the study. If a language editor has made significant revision of the manuscript, we recommend that you acknowledge the editor by name, where possible.

The role of scientific (medical) writer must be included in the acknowledgment section, including their source(s) of funding. We suggest wording such as ‘We thank Jane Doe who provided medical writing service on behalf of XYZ Pharmaceuticals Ltd’. Authors should obtain permission to acknowledge from all those mentioned in the acknowledgment section.

Endnotes

Endnotes should be designed within the text using a superscript lowercase letter and all notes (along with their corresponding letter) should be included in the Endnotes section. Please format this section in paragraph rather than a list.

References

All references, including URLs, must be numbered consecutively, in square brackets, in the order in which they are cited in the text, followed by any in tables or legends. Each reference must have individual reference number. Please avoid excessive referencing. If automatic numbering system are used, the reference numbers must be finalized and the bibliography must be fully formatted before submission. Only articles, datasets and abstracts that have been published or are in press, or are available through public e-print/preprint servers, may be cited; unpublished abstracts, unpublished data and personal communications should not be included in reference list, but may be included in the text and referred to as “unpublished observation” or “personal communications” giving the names of the involved researchers. Obtaining permission to quote personal communication and unpublished data from the cited colleagues is the responsibility of the author. Footnotes are not allowed, but endnotes are permitted. Journal abbreviations follow Index Medicus/MEDLINE. Citations in the reference list should include all named authors, up to the first 30 before adding ‘et al.’

Any in press article cited within the references and necessary for the reviewers’ assessment of the manuscript should be made available if requested by the editorial office. Examples of the NDJMMR reference style are showed below. Please ensure that the reference style is followed precisely; if the references are not in the correct style they may have to be retyped and carefully proofread.

All we links and URLs, including links to authors’ own websites, should be given a reference number and included in the reference list rather than within the text of the manuscript.

They should be provided in full, including both the title of the site and URL, in the following format: The Mouse Tumor Biology Database

[http://tumor.informatics.jax.org/mtbwi/index.do].

If an author or group of authors can clearly be associated with web link, such as for weblogs, then they should be included in the reference.

Example of the NDJMMR reference style

Article within journal

Koonin EV, Altschul SF, Bork P. BRCAI protein products: functional motifs. Nat Genet 1996, 13:266-267.

Article within a journal supplement

Orengo CA, Bary JE, Hubbard T, LoConte L, Silitoe I. Analysis and assessment of ab initio three dimensional prediction, secondary structure, and contacts prediction. Proteins 1999, 43(suppl3):149-170.

In press article

Kharitonov SA, Barnes PJ. Clinical aspect of exhaled nitri oxide. EurRespir J, inpress.

Published abstract

Zvaifler NJ, Burger JA, Marinova-Mutafchieva L, Taylor P, Maini RN. Mesenchymal cells, stromal derived factor-1 and rheumatoid arthritis [abstract]. Arthritis Rheum 1999, 42:s250.

Article within conference proceedings

Jones X. Zeolities and synthetic mechanism. In Proceedings of the First National Conference on Porous sieves: 27-30 June 1996: Baltimore. Edited by Smith Y. Stoneham: Butterwork-Heinemann; 1996:16-27

Book chapter or article within a book

Schnepf E. From prey via endosumbiont to plastids: comparative studies in dinflagellates.

In: Origin of Plastids. Volume 2. 2^nd edition. Edited by Lewin RA. New York: Chapman and Hall; 1993:53-76

Whole issue of journal

Ponder B, Johnston S, CHodosh L (Eds). Innovative oncology. In Breast Cancer Res 1998, 10:1-72

Whole conference proceedings

Smith Y (Ed): Proceeding of the First national Conference on Porous Sieves: 27-30 June 1996; Balitmore. Stoneham: Butterworth-Heinemann; 1996.

Complete book

Margulis L. Origin of Eukaryotic Cells. New Haven: YaleUniversity Press; 1970.

Monograph or book in a series

HumminghakaGW, Gadek JE. The alveolar macrophage. In Cultured Human Cells and Tissue. Edited by Harris TJR. New York: Academic Press; 1995:54-56. [Stoner G (Series Editor): Methods and Perspective in Cell Biology. Vol. 1.]

Book with institutional author

Advisory Committee on Genetic Modification. Annual Report. London; 1999

Preparing tables

Each table should be numbered and cited in sequencing using Arabic numerals (i.e. Table 1, 2, 3 etc.). Tables should also have a title (above the table) that summarizes the whole table; it should be no longer than 15words. Detailed legends may then follow, but they should be concise. Table should always be cited in text in consecutive numerical order. Columns and rows of data should be made visible distinct by ensuring that the borders of each cells display as black lines.

Commas should not be used to indicate numerical values. Colour and shading may not be used; parts of the table can be highlighted using symbols or bold text, the meaning of which should be explained in the table legend. Tables should not be embedded as figures or spreadsheet files.

Style and language

General

Currently, NDJMMR can only accept manuscripts written in English. Spelling should be US English or British English, but not a mixture. There is no explicit limit on the length of article submitted, but authors are encouraged to be concise. There is also no restriction on the number of figures, tables or additional files that can be included with each article online. Figures and tables should be numbered in the order in which they are referred to in the text. Authors should include all relevant supporting data with each article.

NDJMMR will not edit submitted manuscript for style or language; reviewers may advise rejection of a manuscript if it is compromised by grammatical errors. Authors are advised to write clearly and simply, and to have their article checked by colleagues before submission. In house copyediting will be minimal. Non-native speakers English may choose to make use of a copyediting service.

Abbreviations

Abbreviations should be used as sparingly as possible. They should be defined when first used and a list of abbreviations can be provided following the main manuscript text.

Typography

• Please use double line spacing.
• Type the text unjustified, without hyphenating works in line breaks.
• Use hard return only to end headings and paragraphs, not to rearrange lines.
• Capitalize only the first word, and proper nouns, in the title.
• All pages should be numbered
• Use the NDJMMR reference format.
• Footnote are not allowed, but endnotes are permitted.
• Please do not format the text in multiple columns.
• Greek and other special characters may be included. If you are unable to reproduce a particular special character, please type out the name of the symbol in full. Please ensure that all special characters used are embedded in the text, otherwise they will be lost during conversion to PDF.

Units

SI units should be used throughout (liter and molar are permitted, however).

Proofs and Reprints:

Electronic proof will be sent (e-mail attachment) to the corresponding author as a PDF file. Page proofs are considered to be the final version of the manuscript. With the exception of typographical or minor clerical errors, no changes will be made in the manuscript at the proof stage. Because the NDJMMR will be published freely online to attract a wide audience), authors will have free electronic access to full text (in PDF) of the article. Authors can freely download the PDF file from which they can print unlimited copies of their articles.

Copyright:

Submission of a manuscript implies; that the work described has not been published before (except in the form of an abstract or as part of a published lecture, or thesis) that is not under consideration for publication elsewhere; that if and when the manuscript is accepted for publication, the author agree to automatic transfer of the copyright to the publisher.

Fees and Charges: 

There is no fee for submission of manuscript to the NDJMMR. For now, until reviewed, authors are NOT required to pay article publication charge (APC) for publication in the NDJMMR. The Pdf formats of articles published in the journal and of the e-journal can be downloaded without charge on the NDJMMS website.